Search clinical trials for: PBC-40

Total 3183 results

Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University; National Institute for Health Research, United Kingdom; Department of Health, United Kingdom

Completed

B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis (RITPBC)

Fatigue | Primary Biliary Cirrhosis

United Kingdom
Sanmai Technologies PBC dba Sanmai

Recruiting

The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology

Anxiety Disorders

United States
Arizona State University

Recruiting

Daily Vinegar Ingestion and 24-Hour Blood Glucose Control

Glucose Intolerance

United States
Arizona State University

Completed

Daily Vinegar Ingestion and Metabolic Health

Depression | Inflammation | Metabolic Syndrome

United States
Centre Hospitalier Intercommunal Creteil

Not yet recruiting

Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation (LUMASCAN-2)

the Rate of Participation in Screening for PBC
Needed PBC

Recruiting

Prenatal Nutrient Status Study

Pregnancy Related | Nutrient Deficiency

United States
Arizona State University

Recruiting

Anaerobic Exercise and Mental Acuity

Depression | Mood | LPS

United States
Radicle Science

Completed

Evaluation of Effects of CBD Products on Anxiety Among U.S. Women

Generalized Anxiety Disorder | Anxiety

United States
Big Bold Health, PBC
TruDiagnostic

Completed

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

Inflammation | Aging | Immunity Disorders

United States
Anqing Municipal Hospital

Completed

Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery

Dexmedetomidine | Lidocaine | Quality of Recovery(QoR-40), Preoperative and Postoperative

China
University of Alberta
Canadian Institutes of Health Research (CIHR); Gilead Sciences; Abbott

Completed

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

Primary Biliary Cirrhosis

Canada
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome) | Severe Aplastic Anemia

United States
Ondokuz Mayıs University

Recruiting

The Contribution of Intrathecal Morphine Administration to Postoperative Patient Satisfaction During Cesarean Delivery (ITM)

Cesarean Section | Intrathecal Morphine | Quality of Recovery 40

Turkey
Mirum Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Primary Biliary Cirrhosis | PBC

United States, United Kingdom, Canada
CymaBay Therapeutics, Inc.

Terminated

Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis (PBC)

Germany, United States, Canada, United Kingdom, Poland
CymaBay Therapeutics, Inc.

Recruiting

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) (IDEAL)

Primary Biliary Cholangitis

United States
CymaBay Therapeutics, Inc.

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (AFFIRM)

Primary Biliary Cholangitis

United States, Korea, Republic of, Turkey
CymaBay Therapeutics, Inc.

Recruiting

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Hepatic Impairment | Compensated Cirrhosis | Primary Biliary Cholangitis

Korea, Republic of, United States, Spain, United Kingdom
CymaBay Therapeutics, Inc.

Completed

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Primary Biliary Cholangitis

United States, Spain, France, Korea, Republic of, Denmark, Australia, Italy, United Kingdom, Belgium, Canada, Russian Federation, Romania, Germany, Hungary, Mexico, Turkey, Argentina, Austria, Chile, Czechia, Greece, Israel, New Zealand and more
CymaBay Therapeutics, Inc.

Completed

Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

United States, Germany, United Kingdom, Canada
CymaBay Therapeutics, Inc.

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

United States, Korea, Republic of, Belgium, Spain, France, Switzerland, Romania, United Kingdom, Austria, Israel, Australia, Argentina, Canada, Chile, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Poland, Czechia, New Zealand, Turke... and more
CymaBay Therapeutics, Inc.

Completed

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Primary Biliary Cholangitis

United States, Spain, United Kingdom, Israel, France, Korea, Republic of, Australia, Italy, Hungary, Germany, Romania, Belgium, Canada, Greece, New Zealand, Austria, Serbia, Russian Federation, Argentina, Mexico, Netherlands, Chile, Polan...
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Spain, Canada, Australia, United Kingdom, Germany, Netherlands, Belgium, Austria, France
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
Assistance Publique - Hôpitaux de Paris

Completed

Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis (BEZURSO)

PBC

France
Beijing Trendful Kangjian Medical Information Consulting...

Completed

Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC

Cholestatic Liver Disease

China
Fast Forward Pharmaceuticals

Unknown

Pilot Study of FFP104 Dose Escalation in PBC Subjects

Primary Biliary Cirrhosis

Netherlands, United Kingdom
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
University of California, Berkeley
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Parent-Adolescent Interpersonal Processes in the Science of Behavior Change

Sleep Deprivation | Adolescent Behavior

United States
Cardiocentro Ticino

Terminated

METHOD - Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease

Chronic Ischemic Heart Disease

Switzerland
Universitätsklinikum Hamburg-Eppendorf
Abbott Medical Devices; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Completed

SORT - AF Supervised Obesity Reduction Trial for AF Ablation Patients (SORT-AF)

Obesity | Atrial Fibrillation | Sleep Apnea

Germany
University of Pittsburgh

Completed

Study Looking at the Recovery of New Onset Cardiomyopathy

Cardiomyopathy

United States, Canada
RenJi Hospital

Completed

Early Identification of Myocardial Impairment in PBC (EARLY-MYO-PBC)

Cardiovascular Abnormalities | Primary Biliary Cholangitis

China
Foundation for Liver Research

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Chronic Hepatitis B

Netherlands
Meir Medical Center
Clalit Health Services; Reidman college

Unknown

Does Acupuncture Therapy Reduce the Need for Labor Induction After Postdate (Week 41)

Post-term Pregnancy (40 to 42 Weeks Gestation)

Israel
Lung Biotechnology PBC

Completed

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Lung Biotechnology PBC

Terminated

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension (BEAT OLE)

Pulmonary Arterial Hypertension

United States, Israel
Lung Biotechnology PBC

Completed

Beraprost-314d Added-on to Tyvaso® (BEAT) (BEAT)

Pulmonary Arterial Hypertension

United States, Israel
Lung Biotechnology PBC

Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

Pulmonary Arterial Hypertension

United States, Ireland, Belgium
Lung Biotechnology PBC

Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Ireland
Lung Biotechnology PBC

Withdrawn

A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor

Pulmonary Arterial Hypertension
The Danish Research Centre for Chemical Sensitivities

Completed

Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity

Multiple Chemical Sensitivity

Denmark
George Brewer
FDA Office of Orphan Products Development

Completed

Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States
Richard Burt, MD
Northwestern Memorial Hospital

Withdrawn

Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
Azienda U.S.L. 1 di Massa e Carrara

Completed

RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD (RAD2016)

Breast Cancer in Women Under 40 Years Old
The Cleveland Clinic

Completed

A Real-Time Ultrasound Guided Approach For Spinal Anesthesia

Scoliosis | Patients Aged 55 or Older | BMI More Than 40 kg/m2

United States
Wuling Ou
Jiangsu HengRui Medicine Co., Ltd.; Hubei Clinical Research Collaboration Group

Unknown

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Nonsmall Cell Lung Cancer

China
Mayo Clinic

Withdrawn

Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis (PBC)

Autoimmune Hepatitis | Primary Biliary Cirrhosis
Peking Union Medical College Hospital

Recruiting

Clinical Research of UCDA Reducing Medication Regimen in Stable PBC (UCDA PBC)

Primary Biliary Cholangitis

China
Region Örebro County

Not yet recruiting

Regional Distribution of Ventilation at Different Respiratory Rates

Mechanical Ventilation | Atelectasis | Distribution of Ventilation

Search clinical trials for: PBC-40

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations